Effect of the opioid crisis on the liver transplantation donor pool: A national analysis
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Yutaka Endo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Drug Overdose, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Over the last decade there has been a surge in overdose deaths due to the opioid crisis. We sought to characterize the temporal change in overdose donor (OD) use in liver transplantation (LT), as well as associated post‐LT outcomes, relative to the COVID‐19 era.
Methods
LT candidates and donors listed between January 2016 and September 2022 were identified from the Scientific Registry of Transplant Recipients database. Trends in LT donors and changes related to OD were assessed pre‐ versus post‐COVID‐19 (February 2020).
Results
Between 2016 and 2022, most counties in the United States experienced an increase in overdose‐related deaths ( n = 1284, 92.3%) with many counties ( n = 458, 32.9%) having more than a doubling in drug overdose deaths. Concurrently, there was an 11.2% increase in overall donors, including a 41.7% increase in the number of donors who died from drug overdose. In pre‐COVID‐19 overdose was the 4th top mechanism of donor death, while in the post‐COVID‐19 era, overdose was the 2nd most common cause of donor death. OD was younger (OD: 35 yrs, IQR 29–43 vs. non‐OD: 43 yrs, IQR 31–56), had lower body mass index (≥35 kg/cm 2 , OD: 31.2% vs. non‐OD: 33.5%), and was more likely to be HCV+ (OD: 28.9% vs. non‐OD: 5.4%) with lower total bilirubin (≥1.1 mg/dL, OD: 12.9% vs. non‐OD: 20.1%) (all p < .001). Receipt of an OD was not associated with worse graft survival (HR .94, 95% CI .88–1.01, p = .09).
Conclusions
Opioid deaths markedly increased following the COVID‐19 pandemic, substantially altering the LT donor pool in the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
- Department of Surgery, Stanford University, Stanford, California, USA.
ORCID-Profile: Ashley Limkemann, Timothy M Pawlik
Zitieren
APA
Endo, Y., Sasaki, K., Munir, M. M., Woldesenbet, S., Tsilimigras, D. I., Katayama, E., Yang, J., Limkemann, A., Schenk, A., Washburn, K., & Pawlik, T. M. (2024). Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. https://doi.org/10.1111/ctr.15290
Vancouver
Endo Y, Sasaki K, Munir MM, Woldesenbet S, Tsilimigras DI, Katayama E, et al. Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. 2024. doi:10.1111/ctr.15290
BibTeX
@article{Endo2024,
author = {Endo, Yutaka and Sasaki, Kazunari and Munir, Muhammad Musaab and Woldesenbet, Selamawit and Tsilimigras, Diamantis I and Katayama, Erryk and Yang, Jason and Limkemann, Ashley and Schenk, Austin and Washburn, Kenneth and Pawlik, Timothy M},
title = {Effect of the opioid crisis on the liver transplantation donor pool: A national analysis},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15290}
}
EUVIMED